Loading...
So-Young International Inc.
SY•NASDAQ
Healthcare
Medical - Healthcare Information Services
$4.64
$-0.09(-1.90%)
So-Young International Inc. (SY) Financial Performance & Income Statement Overview
Review So-Young International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.09%
↓ 2.09%
Operating Income Growth
-922.97%
↓ 922.97%
Net Income Growth
-2870.33%
↓ 2870.33%
Operating Cash Flow Growth
-100.00%
↓ 100.00%
Operating Margin
-43.65%
↓ 43.65%
Gross Margin
58.38%
↑ 58.38%
Net Profit Margin
-41.60%
↓ 41.60%
ROE
-28.39%
↓ 28.39%
ROIC
-30.68%
↓ 30.68%
So-Young International Inc. (SY) Income Statement & Financial Overview
Review So-Young International Inc.'s (SY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $369.21M | $371.82M | $407.38M | $318.28M |
| Cost of Revenue | $153.05M | $142.17M | $155.05M | $117.31M |
| Gross Profit | $216.16M | $229.66M | $252.33M | $200.97M |
| Gross Profit Ratio | $0.59 | $0.62 | $0.62 | $0.63 |
| R&D Expenses | $42.75M | $40.19M | $42.50M | $39.59M |
| SG&A Expenses | $232.47M | $184.78M | $203.11M | $198.21M |
| Operating Expenses | $815.23M | $224.97M | $245.60M | $237.80M |
| Total Costs & Expenses | $968.28M | $367.14M | $400.66M | $355.12M |
| Interest Income | $0.00 | $14.24M | $11.72M | $12.31M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $11.52M | $0.00 | $11.52M | $11.52M |
| EBITDA | -$47.54M | $4.68M | $6.72M | -$25.31M |
| EBITDA Ratio | -$0.13 | $0.01 | $0.02 | -$0.08 |
| Operating Income | -$599.07M | $4.68M | $6.72M | -$36.83M |
| Operating Income Ratio | -$1.62 | $0.01 | $0.02 | -$0.12 |
| Other Income/Expenses (Net) | -$6.77M | $18.26M | $10.83M | $14.09M |
| Income Before Tax | -$605.84M | $22.94M | $17.55M | -$22.74M |
| Income Before Tax Ratio | -$1.64 | $0.06 | $0.04 | -$0.07 |
| Income Tax Expense | $2.13M | $2.10M | -$2.57M | -$2.56M |
| Net Income | -$607.58M | $20.35M | $18.94M | -$21.24M |
| Net Income Ratio | -$1.65 | $0.05 | $0.05 | -$0.07 |
| EPS | -$4.55 | $0.15 | $0.14 | -$0.16 |
| Diluted EPS | -$4.55 | $0.15 | $0.14 | -$0.16 |
| Weighted Avg Shares Outstanding | $133.35M | $132.26M | $134.50M | $134.44M |
| Weighted Avg Shares Outstanding (Diluted) | $133.35M | $132.26M | $135.03M | $134.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan